GlucoSet Overview
Latest Deal Type
Buyout/LBO
GlucoSet General Information
Description
Developer of health monitoring system designed to reduce harmful hypoglycemia. The company's real-time intravascular blood glucose monitoring system delivers continuous and accurate information on the patient's blood glucose level, enabling normalization of glucose levels, without the risk of sudden and dangerously low glucose levels.
Want to dig into this profile?
We’ll help you find what you need
Learn more
GlucoSet Valuation & Funding
| Deal Type |
Date |
Amount |
Raised to Date |
Post-Val |
Status |
Stage |
| 3. Buyout/LBO |
|
|
|
|
Completed |
Pre-Clinical Trials |
| 2. Grant |
24-Feb-2016 |
00.000 |
|
|
Completed |
Pre-Clinical Trials |
| 1. Grant |
17-Oct-2014 |
$24.8K |
|
|
Completed |
Pre-Clinical Trials |
GlucoSet Executive Team (5)
| Name |
Title |
Board Seat |
Contact Info |
| Nicolas Elvemo |
Chief Executive Officer |
|
|
| Lukas Scherer |
Chief Technology Officer |
|
|
| Parvinder Dhillon |
Chief Technology Officer |
|
|
| Dag Hjelme |
Co-Founder |
|
|
1 Former Executive
GlucoSet Board Members (5)
| Name |
Representing |
Role |
Since |
| Erik Fuglseth Ph.D |
Self |
Board Member |
000 0000
|
| Jan Sollid |
Self |
Chairman |
000 0000
|
| Jørgen Nilsen |
Televenture |
Board Member |
000 0000
|
| Kjell Ingebrigtsen Ph.D |
Self |
Board Member |
000 0000
|
| Reinold Ellingsen Ph.D |
GlucoSet |
Board Member |
000 0000
|